Skip to content
DataLookout
Menu

NCT07296146

Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.

StatusCompleted
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 10 words Show 6 more changesShow less
    • Completed without a posted recruiting period
    • Primary completion date changed from estimate of Mar 15, 2026 to Aug 1, 2026
    • Study sites: 0 to 1
    • Study completion date changed from estimate of May 15, 2026 to Aug 15, 2026
    • Start date changed from estimate of Dec 15, 2025 to Feb 1, 2026
    • Secondary endpoints revised (2)
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

- Hemoglobin concentration
Timeframe: at baseline, and 3-months postintervention
- Erythropoietin resistance index (ERI)
Timeframe: at baseline, and 3-months postintervention

Secondary (2)

Serum creatine
Urea Reduction Ratio

Arms and interventions

EPO + ProbioticActive comparator

EPO (4000 IU) + Probiotic

EPOActive comparator

Erythropoietin (Epoetin 4000 IU)

Drugs: Erythropoietin + Probiotic, EPO

Sites

1 site in 1 country

  • Badr University HospitalCairo, Dr, Egypt